Global Hematology Analyzer Market – Industry Trends and Forecast to 2026

  • Pharmaceutical
  • Upcoming Report
  • Oct 2019
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Hematology Analyzer Market By Product and Services (Hematology Products & Services, Hemostasis Products & Services, Immunohematology Products & Services), Price Range (High-End Hematology Analyzers, Mid-Range Hematology Analyzers, Low-End Hematology Analyzers), End User (Hospital Laboratories, Commercial Service Providers, Government Reference Laboratories, Research and Academic Institutes), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026

Market Analysis: Global Hematology Analyzer Market

Global hematology analyzer market estimated to rise at a substantial CAGR of 6.6% in the forecast period of 2019 to 2026. The imminent market report contains data for historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026. The growth of the market can be attributed to the rising blood donation awareness among people.

Market Definition: Global Hematology Analyzer Market

Hematology analyzers are medical devices used to run tests on blood samples in which counting of WBC is performed by Hematology analyzers. This tool is commonly used in clinical labs to characterize blood cell numbers and types. Hematology analyzers are made of several analytical tools, with different preparative procedure. It also controls the plasma level for drugs. These analyzers help in number of diseases, such as anemia, infections and cancer among others.

Market Drivers

  • Rising cases of blood disorders is boosting the market growth
  • Innovations in several field including pharmacogenomics, genetic therapies, hemoglobinopathies, stem cell research and proteomics will propel the growth of the market
  • Adoption of automated hematology instruments amalgamate with rising preferences of high sensitivity hematology testing is also fueling the market in the forecast period
  • Integration of hematology analyzers with flow cytometry will act as a driver for the market growth

Market Restraints

  • Safety alerts and product recalls is hampering the market growth
  • Slow adoption of advanced hematology instruments in emerging countries may hinder the growth of the market
  • Stringent regulatory policies for hematology analyzers will restraint the market in the forecast period

Segmentation: Global Hematology Analyzer Market

By Product and Services

  • Hematology Products & Services

    • Instruments
    • Reagents & Consumables
    • Services

  • Hemostasis Products & Services

    • Instruments
    • Reagents & Consumables
    • Services

  • Immunohematology Products & Services

    • Instruments
    • Reagents & Consumables
    • Services

By Price Range

  • High-End Hematology Analyzers
  • Mid-Range Hematology Analyzers
  •  Low-End Hematology Analyzers

By End User

  • Hospital Laboratories
  • Commercial Service Providers
  • Government Reference Laboratories
  • Research and Academic Institutes

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • South America

    • Brazil
    • Rest of South America

  • Europe

    • Germany
    • Italy
    • U.K.
    • France
    • Spain
    • Netherlands
    • Belgium
    • Switzerland
    • Turkey
    • Russia
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Singapore
    • Thailand
    • Philippines
    • Rest of Asia-Pacific

  • Middle East and Africa

    • South Africa
    • Rest of Middle East & Africa

Key Developments in the Market:

  • In November 2018, PixCell Medical Technologies Ltd. got FDA 510(k) clearance for its product PixCellm Medical’s HemoScreen. This analyzer is use to perform a complete blood count at the point of care. With this clearance the company will enhance its product portfolio in the market
  • In January 2018, Beckman Coulter announced approval of Health Canada's Medical Device License for DxH 900 hematology analyzer and novel early sepsis indicator. The product will help in native-state cellular characterization for early sepsis detection. This innovation will lead Beckman Coulter advancement in clinical diagnostics

Competitive Analysis:

Global hematology analyzer market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of hematology analyzer market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Some of the major companies functioning in global hematology analyzer market are Abbott, Beckman Coulter Inc, HORIBA Ltd, Siemens, Sysmex, NIHON KOHDEN CORPORATION, Bio-Rad Laboratories inc, Johnson & Johnson, Thermo Fisher Scientific,BD, F. Hoffmann-La Roche Ltd, Boule Diagnostics AB., Danaher, Diatron, Erba Diagnostics, Inc., VirtualExpo, Drucker Diagnostics, EKF DIAGNOSTICS HOLDINGS PLC, Ortho Clinical Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co, Ltd and Biosystems S.A among others.

Research Methodology: Global Hematology Analyzer Market

Data assemblage and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technical Writers, Scientists, Promoters, and Investors among others.

Reasons to Purchase this Report

  • Current and future of global hematology analyzer market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19